Novo Nordisk gets CHMP backing for oral GLP-1 agonist Rybelsus in its marketing battle with Eli Lilly, plus positive opinions for Bayer’s diabetes drug Nubeqa, Emergent’s cholera vaccine, and more ...

Bowls made of mushrooms, cups fashioned from seaweed, and detergent-style pods for food: Designers are creating ephemeral alternatives to plastic. But are we ready to accept them?

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead to the loss of vision, according to the EU medicines regulator. After ...

The American investment company Platinum Equity LLC is in talks to acquire the Dutch manufacturer of metal packaging Trivium Packaging NV for $3.5 billion. This is reported in a Platinum press release ...